Neurocrine Biosciences, Inc. (NBIX) To Present At Oppenheimer's 24th Annual Healthcare Conference
12/5/2013 6:09:55 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) To Present At Deutsche Bank (DB) 2013 Biofest And The 25th Annual Piper Jaffray Healthcare Conference
11/27/2013 6:41:06 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) Reports Third Quarter 2013 Results
10/30/2013 6:32:23 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) Announces Conference Call and Webcast to Present Third Quarter 2013 Financial Results
10/23/2013 6:41:11 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) Announces Phase IIb Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia
9/10/2013 9:14:25 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) to Present at the Morgan Stanley Global Healthcare Conference
9/3/2013 6:28:27 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) Announces the Start of Second Phase III Study of Elagolix in Endometriosis
8/29/2013 9:12:59 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) Reports Second Quarter 2013 Results
7/26/2013 9:09:08 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) Announces Conference Call and Webcast to Present Second Quarter 2013 Financial Results
7/19/2013 6:17:37 AM
More...
|
Neurocrine Biosciences, Inc. (NBIX) Announces Completion of Enrollment Into Kinect Study for Treatment of Tardive Dyskinesia
7/2/2013 9:28:00 AM
More...
|
|